Stock NRSN NEUROSENSE THERAPEUTICS LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts NeuroSense Therapeutics Ltd.

Equities

NRSN

IL0011809592

Delayed Nasdaq
Other stock markets
 03:25:25 2024-05-14 pm EDT 		5-day change 1st Jan Change
1.14 USD -0.88% Intraday chart for NeuroSense Therapeutics Ltd. -11.64% +45.21%
07:21pm NeuroSense Partners with PhaseV for ALS Treatment Trial -- Shares Up MT
May. 07 NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NRSN Stock
  4. News NeuroSense Therapeutics Ltd.
  5. Transcripts
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW